|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
47,900,000 |
Market
Cap: |
51.25(M) |
Last
Volume: |
74,257 |
Avg
Vol: |
376,338 |
52
Week Range: |
$1.06 - $2.66 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P SMALLCAP 600 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Enzo Biochem is a diagnostics, clinical lab, and life sciences company. Co.'s operating segments include: Enzo Clinical Lab, which is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies; Enzo Life Sciences, which manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide; Enzo Therapeutics, which is a biopharmaceutical venture that has developed multiple approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, various of which are derived from the work of Enzo Life Sciences.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
417,900 |
Total Buy Value |
$0 |
$0 |
$0 |
$873,769 |
Total People Bought |
0 |
0 |
0 |
5 |
Total Buy Transactions |
0 |
0 |
0 |
14 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cannon Kara |
Chief Executive Officer |
|
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
451,297 |
|
- |
|
Cannon Kara |
Chief Executive Officer |
|
2024-02-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,823) |
301,297 |
|
- |
|
Cannon Kara |
Chief Executive Officer |
|
2024-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,640 |
307,120 |
|
- |
|
Radoff Bradley Louis |
Director |
|
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
79,365 |
4,390,882 |
|
- |
|
Pully Steven J |
Director |
|
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
79,365 |
97,095 |
|
- |
|
Tagliaferri Mary |
Director |
|
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
79,365 |
312,383 |
|
- |
|
Pully Steven J |
Director |
|
2023-10-30 |
4 |
A |
$0.00 |
$0 |
D/D |
17,730 |
17,730 |
|
- |
|
Cannon Kara |
Chief Operating Officer |
|
2023-08-31 |
4 |
D |
$1.54 |
$98,098 |
D/D |
(63,700) |
296,480 |
|
- |
|
Cannon Kara |
Chief Operating Officer |
|
2023-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
345,080 |
360,180 |
|
- |
|
Wolf James G. |
10% owner until 2/13/2023 |
|
2023-02-13 |
4 |
B |
$1.29 |
$6,450 |
I/I |
5,000 |
115,000 |
0.01 |
50% |
|
Wolf James G. |
10% owner until 2/13/2023 |
|
2023-02-13 |
4 |
B |
$1.29 |
$6,425 |
D/D |
5,000 |
4,100,000 |
2.44 |
50% |
|
Walters Ian B. |
Director |
|
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
75,188 |
155,917 |
|
- |
|
Wolf James G. |
10% owner until 2/13/2023 |
|
2023-02-10 |
4 |
B |
$1.29 |
$6,450 |
D/D |
5,000 |
4,095,000 |
2.44 |
50% |
|
Radoff Bradley Louis |
Director |
|
2023-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
75,188 |
4,311,517 |
|
- |
|
Tagliaferri Mary |
Director |
|
2023-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
75,188 |
155,917 |
|
- |
|
Wolf James G. |
10% Owner |
|
2023-01-27 |
4 |
B |
$1.40 |
$16,520 |
D/D |
11,800 |
4,090,000 |
2.37 |
55% |
|
Wolf James G. |
10% Owner |
|
2023-01-23 |
4 |
OE |
$2.50 |
$744,250 |
D/D |
263,200 |
4,078,200 |
|
- |
|
Cannon Kara |
Chief Operating Officer |
|
2022-12-28 |
4 |
A |
$0.00 |
$0 |
D/D |
12,600 |
15,100 |
|
- |
|
Wolf James G. |
10% Owner |
|
2022-12-16 |
4 |
OE |
$2.50 |
$84,250 |
D/D |
33,700 |
3,815,000 |
|
- |
|
Wolf James G. |
10% Owner |
|
2022-12-15 |
4 |
OE |
$2.50 |
$212,750 |
D/D |
85,100 |
3,781,300 |
|
- |
|
Wolf James G. |
10% Owner |
|
2022-12-14 |
4 |
OE |
$2.50 |
$340,500 |
D/D |
136,200 |
3,696,200 |
|
- |
|
Erfanian Hamid |
Chief Executive Officer |
|
2022-11-23 |
4 |
B |
$1.97 |
$197,000 |
D/D |
100,000 |
374,600 |
2.81 |
23% |
|
Wolf James G. |
10% Owner |
|
2022-11-21 |
4 |
OE |
$2.50 |
$61,750 |
D/D |
24,700 |
3,560,000 |
|
- |
|
Wolf James G. |
10% Owner |
|
2022-11-17 |
4 |
OE |
$2.50 |
$750 |
D/D |
300 |
3,535,300 |
|
- |
|
Eckert Patricia |
Interim CFOOfficer |
|
2022-11-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
11,392 |
|
13% |
|
264 Records found
|
|
Page 1 of 11 |
|
|